- About Us
- Research & Pipeline
- Investor Centre
- Media Centre
Kazia would like to share a video interview with leading cancer researcher at the Hunter Medical Research Institute and The University of Newcastle, Dr Matt Dun.
To mark World Brain Tumour Day, Dr Dun kindly shared some of his time recently to discuss Diffuse Intrinsic Pontine Glioma (DIPG) – the most aggressive form of childhood brain cancer.
DIPG is a deadly disease, with a survival rate of less than 1%, and most commonly affects children between four and 11 years old.
Dr Dun began his research program into the disease after his daughter – Josie, 3 – was sadly diagnosed with DIPG last year. His research is particularly focused on predicting the progression of DIPG in its early stages and testing new therapies in a bid to improve survival.
Kazia’s brain cancer drug GDC-0084 is one of the therapies he has been working with.
In the video, Dr Dun talks about:
Watch the video below.